268. Nakajo-Nishimura syndrome Disease details / Clinical trials / Drug dev / DR info


Clinical trials : 2 Drugs : 3 - (DrugBank : 1) / Drug target genes : 2 - Drug target pathways : 37

Nakajo-Nishimura syndrome and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)